• Colorectal8
• Esophageal/GEJ/Gastric4
• Liver/Cholangio/Gall Bladder1
• Pancreatic6
• Neuroendocrine0
• Other1

• Protocols

• NCI10495

  OPEN TO ACCRUAL

  Ph1 Study of DS-8201a in Combination with Neratinib in Solid Tumors with HER2 Alterations
  
  

• UW26057

  OPEN TO ACCRUAL

  Ph3 Randomized Atebimetinib + modified Gem + nab-Pac vs. standard Gem + nab-Pac in mets PDAC